LTB4-induced Nasal Gland Serous Cell Secretion Mediated by Neutrophil Elastase
- 1 August 1999
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 160 (2) , 411-414
- https://doi.org/10.1164/ajrccm.160.2.9808117
Abstract
Local allergen challenge causes nasal hypersecretion and also causes local leukotriene (LT) release, including LTB(4). Because LTB(4) causes leukocyte recruitment, and because neutrophil elastase is a potent secretagogue, we examined the hypothesis that LTB(4) causes nasal hypersecretion via neutrophil elastase. We developed a method for isolating and superfusing a nasal segment in dogs. Instillation of LTB(4) into the nasal segment caused a time-dependent increase in the volume of airway fluid, in lysozyme secretion, and in the recruitment of neutrophils. ICI 200,355, a selective inhibitor of neutrophil elastase, prevented LTB(4)-induced nasal secretion and lysozyme secretion, but it had no effect on neutrophil recruitment. We conclude that LTB(4) causes potent nasal secretion via release of elastase, and therefore LTB(4) may play a major role in allergic nasal hypersecretion.Keywords
This publication has 19 references indexed in Scilit:
- Biology and pathophysiology of leukotrienesCritical Reviews in Oncology/Hematology, 1996
- Current concepts about neutrophil granule physiologyCurrent Opinion in Hematology, 1996
- Neurokinin receptors subserving airways secretionCanadian Journal of Physiology and Pharmacology, 1995
- Inhibition of human neutrophil elastase by ICI 200,355European Journal of Pharmacology, 1991
- Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells.Journal of Clinical Investigation, 1990
- Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability.Journal of Clinical Investigation, 1989
- Leukotriene B4 as a mediator of early and late reactions to antigen in humans: The effect of systemic glucocorticoid treatment in vivoJournal of Allergy and Clinical Immunology, 1989
- Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to RagweedNew England Journal of Medicine, 1984
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980
- SERUM AND URINARY LYSOZYME (MURAMIDASE) IN MONOCYTIC AND MONOMYELOCYTIC LEUKEMIAThe Journal of Experimental Medicine, 1966